返回 Agenda
Session 6: Patient Contributed Data
Session Chair(s)
Marni Hall, PhD, MPH
Vice President and General Manager, Global Regulatory Science and Strategy
IQVIA, United States
This session will focus on patient-generated health data (PGHD). Different types of PGHD, such as structured and unstructured forms, and criteria for their use will be discussed. Case studies of assessment and application of use of PGHD for clinical and regulatory decision-making will be shared. Concrete steps for advancing greater use of PGHD will be outlined
Learning Objective : At the conclusion of this session, participants should be able to:- Describe different types of PGHD
- Formulate evaluation method(s) to validate use of PGHD for a specific purpose
- Identify opportunities for pilot projects to advance the use of PGHD
Speaker(s)
23andMe: Innovation in Clinical Trial Recruitment
Emily Drabant Conley, PhD
23andMe, United States
Vice President of Business Development
Patient Contributed Data
Christine Lemke
Evidation Heath, Inc., United States
Co-Founder & President
Patient Contributed Data
Sally Okun, BSN, MHS, MBA, RN
Clinical Trials Transformation Initiative (CTTI), United States
Executive Director